[Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
Katsnel'son
L A
LA
Maslova-Khoroshilova
I P
IP
Eliseeva
R F
RF
Dnestrova
G I
GI
D000293:Adolescent; D000328:Adult; D000818:Animals; D000831:Animals, Newborn; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009843:Oligoribonucleotides; D010857:Pigment Epithelium of Eye / Q000187:drug effects / Q000648:ultrastructure; D051381:Rats; D012162:Retinal Degeneration / Q000151:congenital / Q000188:drug therapy* / Q000473:pathology; D012174:Retinitis Pigmentosa / Q000151:congenital / Q000188:drug therapy* / Q000473:pathology; D012265:Ribonucleotides / Q000627:therapeutic use*; D058609:Visual Field Tests
D009843:Oligoribonucleotides; D012265:Ribonucleotides; C031373:ENKAD
Rezul'taty lecheniia preparatom ENKAD bol'nykh s perifericheskoĭ tapetoretinal'noĭ abiotrofieĭ.